NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

Search

Coloplast A-S (Class B)

Fermé

442 1.1

Résumé

Variation du prix de l'action

24h

Actuel

Min

437.6

Max

442.1

Chiffres clés

By Trading Economics

Revenu

522M

1.4B

Ventes

83M

7B

P/E

Moyenne du Secteur

24.901

56.063

BPA

6.32

Rendement du dividende

5.27

Marge bénéficiaire

19.835

Employés

16,983

EBITDA

309M

2.3B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

5.27%

2.45%

Prochains Résultats

12 mai 2026

Date du Prochain Dividende

20 mai 2026

Date du Prochain Détachement de Dividende

18 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-19B

99B

Ouverture précédente

440.9

Clôture précédente

442

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 avr. 2026, 04:27 UTC

Principaux Événements d'Actualité

Singapore PM Warns That Fallout From Mideast War Could Outlast Conflict

3 avr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 avr. 2026, 18:30 UTC

Principaux Événements d'Actualité

An F15-E Just Went Down in Iran. What to Know About the $30 Million Jet. -- Barrons.com

3 avr. 2026, 18:14 UTC

Market Talk

Eli Lilly Seen as Possible GLP-1 Leader With New Pill Approval -- Market Talk

3 avr. 2026, 17:50 UTC

Market Talk

Microsoft's AI Development Will Weigh on Near-Term Azure Growth -- Market Talk

3 avr. 2026, 17:44 UTC

Acquisitions, Fusions, Rachats

SBA Stock Just Had a Big Day. Why It's Suddenly Hot. -- Barrons.com

3 avr. 2026, 16:50 UTC

Principaux Événements d'Actualité

An F15-E Just Went Down in Iran. What to Know About the $90 Million Jet. -- Barrons.com

3 avr. 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 avr. 2026, 16:12 UTC

Résultats

Oil Stocks Look Tapped Out. Why It's Time to Move Into Other Sectors. -- Barrons.com

3 avr. 2026, 15:56 UTC

Market Talk
Principaux Événements d'Actualité

Crypto Markets May Be Active Over Holiday Weekend -- Market Talk

3 avr. 2026, 15:56 UTC

Market Talk
Principaux Événements d'Actualité

Global Equities Roundup: Market Talk

3 avr. 2026, 15:56 UTC

Market Talk
Principaux Événements d'Actualité

Global Forex and Fixed Income Roundup: Market Talk

3 avr. 2026, 15:20 UTC

Principaux Événements d'Actualité

Berkshire, Travelers Join U.S. Plan to Insure Shippers in the Hormuz Strait -- Barrons.com

3 avr. 2026, 15:08 UTC

Acquisitions, Fusions, Rachats

OpenAI Makes Surprise Media Acquisition Ahead of IPO. Why It Will Fail. -- Barrons.com

3 avr. 2026, 14:11 UTC

Market Talk
Principaux Événements d'Actualité

Oil Shock From War in Iran May Show Up In 2Q Job Growth Data -- Market Talk

3 avr. 2026, 12:56 UTC

Market Talk

Treasury Yields, Dollar Higher Following Robust March Hiring -- Market Talk

3 avr. 2026, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 avr. 2026, 08:01 UTC

Market Talk

Global Equities Roundup: Market Talk

3 avr. 2026, 08:01 UTC

Market Talk

Meituan's Profitability Likely to Improve This Year -- Market Talk

3 avr. 2026, 07:45 UTC

Market Talk

LG Electronics Could Post Above-Consensus 1Q Earnings -- Market Talk

3 avr. 2026, 06:17 UTC

Market Talk

Naver Likely to Post Below-Consensus 1Q Earnings -- Market Talk

3 avr. 2026, 06:17 UTC

Market Talk

Global Equities Roundup: Market Talk

3 avr. 2026, 04:33 UTC

Market Talk

China Merchants Port Earnings Likely to Recover This Year -- Market Talk

3 avr. 2026, 04:33 UTC

Market Talk

Global Equities Roundup: Market Talk

3 avr. 2026, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

3 avr. 2026, 04:01 UTC

Market Talk

Posco Holdings 1Q Earnings Could Fall Short of Expectations -- Market Talk

3 avr. 2026, 02:01 UTC

Market Talk

India Consumer-Staple Companies Likely to Post Broadly Steady 4Q Results -- Market Talk

3 avr. 2026, 01:59 UTC

Market Talk

Sea's Shopee E-Commerce Platform Likely in Reinvestment Phase -- Market Talk

3 avr. 2026, 01:44 UTC

Market Talk

Samsung Likely to Report Record Quarterly Earnings in 2026 -- Market Talk

3 avr. 2026, 01:22 UTC

Market Talk

Dollar Could Hit 160 Yen in Thin Holiday Trading -- Market Talk

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat